{"id":1197,"date":"2016-09-08T17:54:24","date_gmt":"2016-09-08T12:24:24","guid":{"rendered":"https:\/\/delveinsightblog.wordpress.com\/?p=1197"},"modified":"2021-07-24T12:56:31","modified_gmt":"2021-07-24T07:26:31","slug":"the-business-cocktail-2","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2","title":{"rendered":"Sun Pharma forms partnership; Pfizer and DCRI collaborate; Avara Acquires AZ; ASLAN Pharmaceutical\u2019s Collaboration; Amgen and Servier partnership"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-69ff1c882f213\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-69ff1c882f213\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2\/#Sun_Pharma_forms_distribution_partnership_with_Mitsubishi_Tanabe_in_Japan\" >Sun Pharma forms distribution partnership with Mitsubishi Tanabe in Japan<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2\/#Pfizer_and_DCRI_collaborated_to_improve_adult_vaccination_rates\" >Pfizer and DCRI collaborated to improve adult vaccination rates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2\/#Avara_Acquires_AstraZeneca_UK_Manufacturing_Facility\" >Avara Acquires AstraZeneca UK Manufacturing Facility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2\/#ASLAN_Pharmaceuticals_Collaboration_with_ASTAR_for_development_of_Antibody_targeting_Zancer\" >ASLAN Pharmaceutical\u2019s Collaboration with A*STAR for development of Antibody targeting Zancer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2\/#The_successful_collaboration_between_Amgen_and_Servier_results_into_Omecamtiv_Mecarbils_advancement_to_Phase_III\" >The successful collaboration between Amgen and Servier results into Omecamtiv Mecarbil\u2019s advancement to Phase III<\/a><\/li><\/ul><\/nav><\/div>\n<h4 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"Sun_Pharma_forms_distribution_partnership_with_Mitsubishi_Tanabe_in_Japan\"><\/span><strong>Sun Pharma forms distribution partnership with Mitsubishi Tanabe in Japan<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p style=\"text-align: justify;\">In a recent strategic move, Sun Pharma formed a distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan for the total of 14 prescription brands which were acquired from Novartis for $293m. The brands are Parlodel, Lamisil, Nitroderm, Apresoline, Zaditen, Symmetrel, Cibacen, Tegretol, Pursennid, Lioresal, Lopresor, Ternelin, Ludiomil and Lochol. After the transfer from Novartis to Sun Pharma subsidiary in Japan, Mitsubishi will be responsible for the marketing as well as the distribution of all the 14 brands.<\/p>\n<h4 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"Pfizer_and_DCRI_collaborated_to_improve_adult_vaccination_rates\"><\/span><strong>Pfizer and DCRI collaborated to improve adult vaccination rates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p style=\"text-align: justify;\">Pfizer, Duke Clinical Research Institute (DCRI), Duke Primary Care, and Premier have recently joined hands to work collectively for the improvisation of adult vaccination rates. The project named Adult Immunisation Poject, funded by Pfizer wil be piloted throught out Duke Primary Care.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Avara_Acquires_AstraZeneca_UK_Manufacturing_Facility\"><\/span><strong>Avara Acquires AstraZeneca UK Manufacturing Facility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p style=\"text-align: justify;\">AstraZeneca\u2019s UK manufacturing facility was acquired by US based Avara Pharmaceutical Services, as per the terms and conditions of the contract, the employees of the AstraZeneca will remain employed and the plant will continue manufacturing critical pharmaceutical products of the AstraZeneca.<\/p>\n<h4 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"ASLAN_Pharmaceuticals_Collaboration_with_ASTAR_for_development_of_Antibody_targeting_Zancer\"><\/span><strong>ASLAN Pharmaceutical\u2019s Collaboration with A*STAR for development of Antibody targeting Zancer<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p style=\"text-align: justify;\">Singapore\u2019s Agency for Science, Technology and Research (A*STAR) provided worldwide development and commercialization license of a novel immuno-oncology antibody targeting RON (Recepteur d\u2019Origine Nantais) to ASLAN pharmaceuticals, an Immuno-Oncology focused biotech company. Clinical studies will commence by 2018. The collaboration also includes a development of Innovative Clinical Program assisted by ASLAN.<\/p>\n<h4 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"The_successful_collaboration_between_Amgen_and_Servier_results_into_Omecamtiv_Mecarbils_advancement_to_Phase_III\"><\/span><strong>The successful collaboration between Amgen and Servier results into Omecamtiv Mecarbil\u2019s advancement to Phase III<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p style=\"text-align: justify;\">Omecamtiv mecarbil, a drug developed under the collaboration between Amgen and Servier for Chronic Heart Failure is reported to enter into Phase III clinical trials. This drug will be commercialized by Servier in Europe as well as in Russian Commonwealth. For this Servier will have to pay $10 million to Amgen. Also, these companies are planning to collaborate with Cytogenetics for the drug\u2019s further development.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sun Pharma forms distribution partnership with Mitsubishi Tanabe in Japan In a recent strategic move, Sun Pharma formed a distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan for the total of 14 prescription brands which were acquired from Novartis for $293m. The brands are Parlodel, Lamisil, Nitroderm, Apresoline, Zaditen, Symmetrel, Cibacen, Tegretol, Pursennid, Lioresal, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1200,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[32],"tags":[17328,831,17326,96,17325,17324,17323,17329,460,17327,802],"industry":[17225],"therapeutic_areas":[17242,17227,17228],"class_list":["post-1197","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizia","tag-a-star","tag-amgen","tag-aslan-pharmaceutical","tag-astrazeneca","tag-avara","tag-dcri","tag-mitsubishi-tanabe","tag-omecamtiv-mecarbil","tag-pfizer","tag-servier","tag-sun-pharma","industry-pharmaceutical","therapeutic_areas-cardiovascular-diseases","therapeutic_areas-immunological-and-autoimmune-disorders","therapeutic_areas-oncology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sun Pharma forms partnership; Pfizer and DCRI collaborate<\/title>\n<meta name=\"description\" content=\"In a recent strategic move, Sun Pharma formed a distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan for the total of 14 prescription...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sun Pharma forms partnership; Pfizer and DCRI collaborate\" \/>\n<meta property=\"og:description\" content=\"In a recent strategic move, Sun Pharma formed a distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan for the total of 14 prescription...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-08T12:24:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-24T07:26:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/09\/15170357\/14130776__original.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sun Pharma forms partnership; Pfizer and DCRI collaborate","description":"In a recent strategic move, Sun Pharma formed a distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan for the total of 14 prescription...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2","og_locale":"en_US","og_type":"article","og_title":"Sun Pharma forms partnership; Pfizer and DCRI collaborate","og_description":"In a recent strategic move, Sun Pharma formed a distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan for the total of 14 prescription...","og_url":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2016-09-08T12:24:24+00:00","article_modified_time":"2021-07-24T07:26:31+00:00","og_image":[{"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/09\/15170357\/14130776__original.jpg","width":1,"height":1,"type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2","url":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2","name":"Sun Pharma forms partnership; Pfizer and DCRI collaborate","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/09\/15170357\/14130776__original.jpg","datePublished":"2016-09-08T12:24:24+00:00","dateModified":"2021-07-24T07:26:31+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"In a recent strategic move, Sun Pharma formed a distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan for the total of 14 prescription...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-2#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/09\/15170357\/14130776__original.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/09\/15170357\/14130776__original.jpg","caption":"Blue globes from drug capsule"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/09\/15170357\/14130776__original.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">A STAR<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Amgen<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">ASLAN Pharmaceutical<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">AstraZeneca<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Avara<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">DCRI<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Mitsubishi Tanabe<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Omecamtiv Mecarbil<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Pfizer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Servier<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Sun Pharma<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">A STAR<\/span>","<span class=\"advgb-post-tax-term\">Amgen<\/span>","<span class=\"advgb-post-tax-term\">ASLAN Pharmaceutical<\/span>","<span class=\"advgb-post-tax-term\">AstraZeneca<\/span>","<span class=\"advgb-post-tax-term\">Avara<\/span>","<span class=\"advgb-post-tax-term\">DCRI<\/span>","<span class=\"advgb-post-tax-term\">Mitsubishi Tanabe<\/span>","<span class=\"advgb-post-tax-term\">Omecamtiv Mecarbil<\/span>","<span class=\"advgb-post-tax-term\">Pfizer<\/span>","<span class=\"advgb-post-tax-term\">Servier<\/span>","<span class=\"advgb-post-tax-term\">Sun Pharma<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 10 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on Sep 8, 2016","modified":"Updated on Jul 24, 2021"},"absolute_dates_time":{"created":"Posted on Sep 8, 2016 5:54 pm","modified":"Updated on Jul 24, 2021 12:56 pm"},"featured_img_caption":"Blue globes from drug capsule","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/1197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=1197"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/1197\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/1200"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=1197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=1197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=1197"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=1197"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=1197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}